Nivolumab during active surveillance after neoadjuvant chemoradiation for esophageal cancer (SANO-3 study) (ESMO-IO 2026) - Oct 25, 2026 - Abstract #160P; Pres time: Dec 14, 2026; 05:30 PM - 06:30 PM; Location: Churchill Room; No abstract available
Clinical • Esophageal Cancer • Oncology
|
|
Tamara Huizer; Esmee A. De Bruijn; Charlèn e Van der Zijden; Lena Van Doorn; Joost Nuyttens; Lindsey Oudijk; Manon Spaander; Esthe r Oomen-de Hoop; Laurens V. Beerepoot; Edward Fiets; Irene Van Helle mond; Marieke Vollebergh; Harm Westdorp; Sjoerd Lagarde; Bas Wijnhoven; Bianca Mostert
|